SUBSCRIBE
SUBSCRIBE
News   Policy

Veridex, LLC Cancer Test Lacks Long Term Data Say US FDA Staff

November 16, 2006 | 
1 min read
WASHINGTON, Nov 15 (Reuters) - Data on Veridex LLC's lab test to quickly detect breast cancer that has spread to lymph nodes lacks long-term information on survival, U.S. regulatory staff said in documents released on Wednesday.

>>> Discuss This Story

Regulatory
MORE ON THIS TOPIC
Podcast
Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus
January 7, 2026
 · 
2 min read
 · 
Heather McKenzie
3D Illustration of unlucky business man under rain, surreal concept
Vaccines
Vaccine Investors Keep Their Heads Down as Trump Cuts Shot Schedule
January 6, 2026
 · 
3 min read
 · 
Dan Samorodnitsky
Business concept, disagreement, dispute, collapse. The gap between two people. Obstacle to the merger.
FDA
FDA Went Against Adcomm Votes More, Held Fewer Meetings in 2025
January 6, 2026
 · 
3 min read
 · 
Heather McKenzie
Doubtful person, hands on hips, choosing the way as multiple arrows on the road showing a mess of different directions. Choosing the correct pathway, difficult decision concept, confusion symbol.
FDA
Calls for Leadership Stability and Rare Disease Follow-Through at FDA in 2026
January 5, 2026
 · 
9 min read
 · 
Tristan Manalac